Eikon Therapeutics Inc. Common Stock

EIKN | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.41

+$0.10 (+1.88%)

Nov 2, 2026, 2:27 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $292.91M

Enterprise Value $8.12M

Beta 0.94

Average Volume 526.6K

Shares Outstanding (Diluted) 54.15M

Shares Change YoY N/A

Institutional Ownership 49.26%

Exchange NASDAQ

ISIN US2825641036

Price Performance

Price Change 1M -26.2%

Price Change 3M -40.9%

Price Change 6M -47.3%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -40.7%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -75.8%

Valuation

PE Ratio -1.15

Forward PE N/A

PEG Ratio 0.01

Forward PEG 0.04

PS Ratio N/A

Forward PS N/A

PB Ratio 0.62

P/FCF Ratio -1.11

P/Adj. FCF Ratio -1.08

P/OCF Ratio -1.12

EV/Sales N/A

EV/EBIT -0.03

EV/EBITDA -0.03

EV/FCF -0.03

Earnings Yield -87.2%

FCF Yield -90.2%

Adj. FCF Yield -92.9%

Financial Health

Net Cash $522.13M

Total Debt $252.22M

Cash & Short-Term Investments $531.58M

Total Assets $779.57M

Current Ratio 9.89

Quick Ratio 9.89

Debt / Equity Ratio 0.54

Debt / EBITDA -0.85

Debt / FCF -0.97

OCF / Debt -1.02

Interest Coverage 0.00

Altman Z-Score -2.00

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -3.0%

Returns

Return on Assets -41.3%

Return on Equity 193.4%

Return on Invested Capital -46.2%

Return on Capital Employed -46.8%

Return on Tangible Assets -41.3%

Analyst Forecasts

Analyst Rating Sell

Analyst Count 1

EPS Growth Next 3Y -9.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$1.74

EPS Growth Est (next Q) -84.9%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $14.00

Price Target Upside 163.7%

Cash Flow

Operating Cash Flow $-256.02M

Free Cash Flow $-259.2M

Adj. Free Cash Flow $-267.05M

FCF Per Share -$4.79

OCF Per Share -$4.73

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-15.25M

Operating Income $-338.65M

EBITDA $-297.15M

Net Income $-322.16M

EPS (Diluted) -$4.63

Revenue / Employee N/A

Profit / Employee $-838.96K

Employees 384